title: [Melkersson-Rosenthal syndrome. Value of reduction cheiloplasty].
abstract: BACKGROUND
  The interest of cheiloplasty is not precisely defined in the treatment of Melkersson-Rosenthal syndrome (MRS).
  
  
  METHODS
  The case of a 32-year-old woman, suffering from a typical MRS is reported. The lack of efficacy of various classical molecules (corticoseroids, hydroxychloroquine, dapsone, colchicine, clofazimine) led to a surgical therapy, consisting in cheiloplasty. Systemic corticosteroids were associated. The result was good, with a follow-up of 2 years.
  
  
  CONCLUSIONS
  Cheiloplasty is essentially of cosmetical interest, in the MRS, once the inflammatory process has been stopped (almost one year). Medical treatment (corticosteroids), is to be continued after surgery, to avoid recurrence.
authors: Service de Dermatologie, Hôpital Nord, CHU de Marseille.
authors: R
authors: R
authors: Rey
authors: J P
authors: JP
authors: Carreau
authors: R
authors: R
authors: Gola
authors: P
authors: P
authors: Berbis
mesh_terms: D000328:Adult; D004954:Esthetics; D005260:Female; D006801:Humans; D008046:Lip / Q000601:surgery*; D008556:Melkersson-Rosenthal Syndrome / Q000188:drug therapy / Q000601:surgery*; D013518:Surgery, Plastic / Q000379:methods; D017211:Treatment Failure
vernacular_title: Syndrome de Melkersson-Rosenthal Intérêt de la chéiloplastie de réduction.